Attached files

file filename
EX-99.1 - Enveric Biosciences, Inc.ex991to8k10211002_08182015.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 18, 2015
 
AMERI Holdings, Inc.
(Exact name of registrant as specified in its charter)
     
Delaware
000-26460
95-4484725
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
     
100 Canal Pointe Building, Princeton, New Jersey
08540
(Address of principal executive offices)
(Zip Code)

Registrant’s telephone number, including area code: (732) 243-9250
 
N/A
(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 
 

 
 
Item 2.02.
Results of Operations and Financial Condition.
 
On August 18, 2015, AMERI Holdings, Inc., a Delaware corporation (the "Company") announced its financial results for the quarter ended June 30, 2015.  A copy of the press release is furnished as Exhibit 99.1 to this report.
 
The information furnished pursuant to this Item 2.02 of this Current Report on Form 8-K, including the exhibit hereto, shall not be considered “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of such section, nor shall it be incorporated by reference into future filings by the Company under the Securities Act of 1933, as amended, or under the Securities Act of 1934, as amended, unless the Company expressly sets forth in such future filing that such information is to be considered “filed” or incorporated by reference therein.
 
Item 9.01.
Financial Statements and Exhibits.
 
(d)           Exhibits
 
 
Exhibit No.
Description

 
99.1
Press Release dated August 18, 2015.
 
 
 

 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
AMERI Holdings, Inc.
 
(Registrant)
   
Date:  August 18, 2015
 
 
By:
/s/ Giri Devanur
   
Name:
Giri Devanur
   
Title:
President and Chief Executive Officer
 
 
 

 
 
EXHIBIT INDEX
 
 
 
Exhibit No.
Description

 
99.1
Press Release dated August 18, 2015.